NCT02541331View on ClinicalTrials.gov

Efficacy Of Bacterial Lysate In Asthmatic Children

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Allergic Asthma
Interventions
BIOLOGICAL

ISMIGEN

Tablets of 30 billion organisms/mg - Sublingual use 1 tablet per day over 10 days for 3 successive months.

BIOLOGICAL

PLACEBO

Matched tablets without any active substance.

Trial Locations (4)

22-100

LASERMED Diagnosis and Treatment Centre, Chełm

20-093

Children University Hospital - Pneumology and Rheumatology Dept, Lublin

20-095

ALERGOTEST s.c. Medical Centre, Lublin

47-120

Medical Centre Lucyna and Andrzej Dymek, Zawadzkie

Sponsors
All Listed Sponsors
lead

Lallemand Pharma AG

INDUSTRY

NCT02541331 - Efficacy Of Bacterial Lysate In Asthmatic Children | Biotech Hunter | Biotech Hunter